$876 Billion is the total value of ORACLE INVESTMENT MANAGEMENT INC's 30 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 52.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXDX | New | ACCELERATE DIAGNOSTICS INC | $104,209,249,000 | – | 4,778,049 | +100.0% | 11.90% | – |
| QDEL | Sell | QUIDEL CORP | $88,914,926,000 | -11.9% | 3,256,957 | -0.3% | 10.16% | -26.9% |
| THC | New | TENET HEALTHCARE CORP | $75,172,219,000 | – | 1,755,950 | +100.0% | 8.58% | – |
| ACOR | ACORDA THERAPEUTICS INC | $74,167,655,000 | +29.8% | 1,956,414 | 0.0% | 8.47% | +7.7% | |
| MZOR | Sell | MAZOR ROBOTICS LTDsponsored ads | $65,296,847,000 | +4.1% | 3,194,562 | -0.6% | 7.46% | -13.6% |
| THOR | Sell | THORATEC CORP | $62,889,665,000 | -17.1% | 1,756,204 | -15.3% | 7.18% | -31.2% |
| OPK | Sell | OPKO HEALTH INC | $51,930,667,000 | +7.2% | 5,571,960 | -2.9% | 5.93% | -11.0% |
| HNSN | Buy | HANSEN MEDICAL INC | $51,111,182,000 | +83.1% | 19,658,147 | +19.7% | 5.84% | +51.9% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $45,853,706,000 | +34.5% | 3,599,192 | +5.5% | 5.24% | +11.6% |
| TTHI | TRANSITION THERAPEUTICS INC | $34,170,674,000 | +40.2% | 4,287,412 | 0.0% | 3.90% | +16.3% | |
| ARAY | ACCURAY INC | $31,104,058,000 | +10.3% | 3,240,006 | 0.0% | 3.55% | -8.5% | |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $22,742,782,000 | +81.2% | 1,846,005 | +70.8% | 2.60% | +50.3% |
| RPRX | New | REPROS THERAPEUTICS INC | $22,038,863,000 | – | 1,242,326 | +100.0% | 2.52% | – |
| VRML | VERMILLION INC | $21,062,882,000 | +26.6% | 7,139,960 | 0.0% | 2.41% | +5.1% | |
| TSRO | Sell | TESARO INC | $18,683,009,000 | -13.9% | 633,752 | -17.5% | 2.13% | -28.5% |
| ECYT | New | ENDOCYTE INC | $15,952,700,000 | – | 670,000 | +100.0% | 1.82% | – |
| BIOL | Buy | BIOLASE INC | $14,787,543,000 | +29.5% | 6,135,910 | +51.9% | 1.69% | +7.4% |
| XON | Sell | INTREXON CORP | $14,459,500,000 | +8.2% | 550,000 | -2.0% | 1.65% | -10.2% |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $13,780,150,000 | +2.3% | 2,575,729 | 0.0% | 1.57% | -15.1% | |
| WBMD | WEBMD HEALTH CORP | $12,425,837,000 | +4.8% | 300,141 | 0.0% | 1.42% | -13.1% | |
| GTIV | Sell | GENTIVA HEALTH SERVICES INC | $7,730,112,000 | -60.4% | 847,600 | -46.1% | 0.88% | -67.1% |
| DSCI | New | DERMA SCIENCES INC | $6,340,000,000 | – | 500,000 | +100.0% | 0.72% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $5,430,000,000 | – | 3,000,000 | +100.0% | 0.62% | – |
| AGEN | New | AGENUS INC | $4,360,763,000 | – | 1,375,634 | +100.0% | 0.50% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,915,000,000 | – | 100,000 | +100.0% | 0.45% | – |
| BIIB | Sell | BIOGEN IDEC INC | $3,526,681,000 | +8.7% | 11,530 | -0.6% | 0.40% | -9.8% |
| MBLX | METABOLIX INC | $2,155,564,000 | +3.2% | 1,658,126 | 0.0% | 0.25% | -14.6% | |
| GTXI | GTX INC DEL | $761,587,000 | -7.3% | 497,769 | 0.0% | 0.09% | -23.0% | |
| LTS | LADENBURG THALMAN FIN SVCS I | $503,884,000 | -3.5% | 166,849 | 0.0% | 0.06% | -19.4% | |
| GILD | New | GILEAD SCIENCES INC | $99,000,000 | – | 50,000 | +100.0% | 0.01% | – |
| AGEN | Exit | AGENUS INC | $0 | – | -1,225,635 | -100.0% | -0.44% | – |
| MAKO | Exit | MAKO SURGICAL CORP | $0 | – | -151,398 | -100.0% | -0.62% | – |
| AXK | Exit | ACCELR8 TECHNOLOGY INC | $0 | – | -4,748,588 | -100.0% | -7.98% | – |
| THC | Exit | TENET HEALTHCARE CORP COM | $0 | – | -1,755,950 | -100.0% | -10.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.